VOYA Investment Management
KYTX icon

VOYA Investment Management’s Kyverna Therapeutics KYTX Stock Holding History

VOYA Investment Management’s Portfolio KYTX Stock Details KYTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-44,045
Closed -$380K – 2569
2026
Q1 		$380K Sell
44,045
-24,095
-35% -$201K ﹤0.01% 1846
2025
Q4 		$641K Buy
+68,140
New +$506K ﹤0.01% 1647

Other funds holding KYTX

GGI
GordonMD Global Investments Beverely Hills, California $207M AUM
GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.32B AUM 1.62% 1-Year Est. Return

VOYA Investment Management's KYTX Position: Q2 2026 in Review

VOYA Investment Management sold out of Kyverna Therapeutics (KYTX) in Q2 2026, closing a stake of 44,045 shares — an estimated $380K sold.

VOYA Investment Management first reported a position in KYTX in Q4 2025 and held it in 2 quarters. The position peaked at $641K in Q4 2025. 120 funds tracked by Wall St. Rank hold KYTX as of Q2 2026.

  • VOYA Investment Management reported no remaining Kyverna Therapeutics position as of Q2 2026 after selling out during the quarter.
  • VOYA Investment Management sold 44,045 Kyverna Therapeutics shares in Q2 2026, an estimated $380K.
  • VOYA Investment Management first reported a position in Kyverna Therapeutics in Q4 2025 and held it in 2 quarters.
  • VOYA Investment Management's Kyverna Therapeutics position peaked at $641K in Q4 2025.
  • 120 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.